[Use of norethindrone .35 mg in disorders of the menstrual cycle].
Ferrari
A N
AN
Berge
I
I
Rosito
C L
CL
Russowsky
M
M
Barbisan
A B
AB
Roeche
T
T
D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D004194:Disease; D004412:Dysmenorrhea; D005193:Family Planning Services; D008599:Menstruation Disturbances; D009640:Norethindrone; D011293:Premenstrual Syndrome; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D009640:Norethindrone
Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--therapeutic use; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--therapeutic use; Contraceptive Agents--administraction and dosage; Contraceptive Agents--therapeutic use; Diseases; Dysmenorrhea; Family Planning; Menstruation Disorders; Norethindrone--administraction and dosage; Norethindrone--therapeutic use; Oral Contraceptives; Premenstrual Tension; Research Methodology